Search for: "Genentech Inc."
Results 81 - 100
of 469
Sorted by Relevance
|
Sort by Date
1 Feb 2008, 1:24 am
According to the IP Kat reporting on Glaxo Group Ltd v Genentech Inc and Biogen Idec Inc. [2008] EWCA Civ 23, the UK Court of Appeal confirmed the Patent Court's decision to permit a British national invalidity proceeding to go forward without suspension, despite the existence of a parallel opposition proceeding at the EPO. [read post]
14 Apr 2014, 4:10 am
The IPKat has just been perusing the meaty yet compact decision in the case of Hospira v Genentech (Hospira UK Ltd v Genentech Inc [2014] EWHC 1094 (Pat) (10 April 2014)) which came out last Thursday from Mr Justice Birss. [read post]
6 Nov 2017, 9:38 pm
Biogen, Inc and Genentech, Inc. [read post]
22 May 2013, 8:34 pm
Genentech, Inc., 549 U.S. 118, 137 (2007), this Court ruled that a patent licensee that believes that its products do not infringe the patent and accordingly are not subject to royalty payments is "not required . . . to break or terminate its . . . license agreement before seeking a declaratory judgment in federal court... [read post]
16 Jan 2007, 10:36 am
Following its win over Genentech on Jan. 9, MedImmune prevailed over J&J's Centocor on Jan. 16 with the Supreme Court saying it can pursue a patent case against Johnson & Johnson subsidiary Centocor Inc. in a lower federal court, even though MedImmune is continuing to pay royalties on a patent held by Centocor.Both the Genentech and Centocor cases presented the issue of whether a company licensing a patent (a licensee) from another company (licensor) must take… [read post]
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am
Sleet in Genentech, Inc. et al. v. [read post]
9 Jul 2008, 3:35 pm
Genentech, Inc., 127 S. [read post]
5 Jul 2009, 8:40 pm
Robert McFarlane, a partner at Townsend and Townsend and Crew LLP, and Chester Chuang, Senior Corporate Counsel at Electronics For Imaging, Inc., will review the recent Federal Circuit rulings in In re TS Tech and In re Genentech, specifically focusing on the ramifications for plaintiffs who wish to continue filing patent infringement suits in the Eastern District of Texas and for defendants who would rather have their cases decided in other jurisdictions. [read post]
12 Mar 2020, 2:36 pm
Connolly in Genentech, Inc. et al. v. [read post]
5 Dec 2011, 1:41 pm
Specifically as to that suit: Ron Leuty wrote in a San Francisco (CA) Business Times (12/2, Subscription Publication) blog posting that “Genentech Inc. will pay $20 million to settle a whistleblower lawsuit around off-label marketing of the cancer-fighting drug Rituxan. [read post]
1 Sep 2009, 12:35 am
"Much like in [In re Genentech, Inc., 566 F.3d 1338 (Fed. [read post]
12 Jul 2017, 9:17 pm
Celltrion, Inc. v Genentech, Inc. [read post]
4 Aug 2011, 9:59 pm
Genentech, Inc., 549 U.S. 764, 777 (2007) (Thomas, J., dissenting), citing Aetna... [read post]
30 Sep 2011, 1:10 pm
" PTI appealed, whereupon the CAFC, citing the Supreme Court's 2007 MedImmune, Inc. v. [read post]
9 Apr 2009, 2:16 pm
Genentech Inc. announced that at least three patients have been infected with the brain infection progressive multifocal leukoencephalopathy (PML) since October. [read post]
25 Feb 2008, 9:30 pm
Reuters noted: Genentech Inc. [read post]
28 Jan 2007, 8:11 pm
Genentech Inc. [read post]
30 Mar 2007, 8:57 am
Supreme Court, in MedImmune, Inc. v. [read post]
27 Jan 2013, 8:57 pm
Aurobindo Pharma Ltd. et al. 1:13-cv-00124; filed January 22, 2013 in the District Court of Delaware • Plaintiffs: Hoffmann-La Roche Inc.; Genentech Inc. [read post]
2 Oct 2023, 9:32 pm
Genentech, Inc. [read post]
